Cell and Tissue Imaging
细胞和组织成像
基本信息
- 批准号:10583247
- 负责人:
- 金额:$ 10.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-12-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAccelerationAnimalsAreaBasic ScienceBehaviorBiological AssayCell physiologyCellsChargeCiliaConsultationsContrast MediaCryoelectron MicroscopyCustomData AnalysesData SetDedicationsDevelopmentDiabetes MellitusDimensionsEducationEducational workshopElectron MicroscopyElectronsEnsureEquipmentExperimental DesignsFacultyFeedbackFluorescenceFundingGenerationsGoalsGrantHeartHuman ResourcesImageImage AnalysisImaging TechniquesImaging technologyImmunohistochemistryIndividualInformaticsInstitutionInvestmentsIonsLaboratoriesLaboratory ResearchLearningLightLiverMacromolecular ComplexesMetabolic DiseasesMethodologyMicro Electron DiffractionMicroscopeMicroscopicMicroscopyMorphologyOpticsPathogenesisPhysiologicalPlayPreparationProcessPropertyProteinsPublicationsResearchResearch PersonnelResolutionRoentgen RaysRoleSamplingScheduleScholarshipServicesSpecialistSpecimenSpeedStructureSystemTechnical ExpertiseTechniquesTechnologyTimeTissue imagingTissuesTrainingTranslational ResearchUniversitiesVisualizationWashingtonWorkX ray microscopybiological researchcellular imagingcostdata acquisitionimaging facilitiesimprovedinnovationinstrumentationisletlight microscopylive cell imagingmembermicroscopic imagingmolecular imagingnew technologyoperationpolypeptideprofessorprogramsquantitative imagingresearch studyresponsesingle moleculesmall moleculesuperresolution imagingsuperresolution microscopytechnology platformtissue fixingtooltranslational studytreatment strategytwo-dimensionaltwo-photon
项目摘要
PROJECT SUMMARY: Cell and Tissue Imaging Core
Advanced cellular microscopy is a powerful tool for biological research and plays an important role in
the study of the pathogenesis and eventual treatment of diabetes mellitus. Imaging technology has evolved
rapidly over the last decade leading to improvements in resolution, sensitivity and speed that have created new
opportunities for studying processes across many orders of magnitude and in real-time in living cells and
animals. However, the costs of increasingly sophisticated equipment are substantial and the expertise to
efficiently use, maintain, and develop this equipment is not common in most labs. There is therefore a
significant gap between the availability of these powerful tools and the ability of investigators to access and use
them efficiently. The Cell and Tissue Imaging Core was established in response to feedback from DRC center
members to leverage the significant institutional investment in the newly created Washington University Center
for Cellular Imaging (WUCCI) by providing an integrated approach to investigate the structure and dynamic
behavior of diabetes-related cells and tissues. The overall objective of the Core is to provide access to
and technical support in using advanced cellular microscopy to accelerate the pace, expand the scope,
and improve the efficiency of diabetes research at Washington University. Core services meet the unique
requirements of numerous investigators over a wide range of basic and translational research and attract new
investigators into diabetes research. Importantly, users benefit from the in-depth diabetes and technical
expertise of the Core directors and technical staff in time spent in consultation for experimental design and
interpretation of data. During the past funding cycle, the Core served 67 DRC investigator research
laboratories (including 14 P&F recipients), who expensed $788,342 in core recharges, representing
approximately 18% of all WUCCI activity. Eighteen DRC member laboratories received micro-grant funding
through the DRC Imaging Core Scholarship program. Ten of these labs were directed by junior faculty
members at the rank of Assistant Professor. Thirty-five publications used and cited core services. Given the
broad use of the Core over the past funding cycle, and the establishment of new imaging technologies (e.g.
cryo-EM and lattice lightsheet), sample preparation services (e.g. tissue clearing), and analysis approaches
(e.g. AI-based immunohistochemistry and immunofluorescent image analysis), it is anticipated that requests for
Cell and Tissue Imaging Core services will continue to grow. The substantial demand by DRC members for
advanced microscopic imaging and image analysis is strong evidence that the Cell and Tissue Imaging Core
provides services that leverage generous institutional support and unique expertise to facilitate important and
innovative diabetes research.
项目摘要:细胞和组织成像核心
先进的细胞显微镜是生物研究的有力工具,在
研究糖尿病的发病机制和最终治疗。成像技术已经发展
过去十年中,分辨率、灵敏度和速度的迅速提高,创造了新的
在活细胞中实时研究多个数量级过程的机会
动物。然而,日益复杂的设备成本高昂,而且需要专业知识
有效地使用、维护和开发该设备在大多数实验室中并不常见。因此有一个
这些强大工具的可用性与调查人员访问和使用的能力之间存在巨大差距
他们有效地。细胞和组织成像核心是根据 DRC 中心的反馈而建立的
成员利用对新创建的华盛顿大学中心的重大机构投资
通过提供一种综合方法来研究细胞成像(WUCCI)的结构和动态
糖尿病相关细胞和组织的行为。核心的总体目标是提供对
和技术支持,加快使用先进细胞显微镜的步伐,扩大范围,
提高华盛顿大学糖尿病研究的效率。核心服务满足独特
众多研究人员对广泛的基础研究和转化研究的需求,并吸引新的
糖尿病研究的研究者。重要的是,用户受益于深入的糖尿病和技术
核心董事和技术人员在实验设计和咨询方面花费的时间的专业知识
数据解释。在过去的资助周期中,核心服务于 67 名 DRC 研究者的研究
实验室(包括 14 个 P&F 接受者),其核心充值费用为 788,342 美元,相当于
约占所有 WUCCI 活动的 18%。十八个刚果民主共和国成员实验室获得小额赠款资助
通过 DRC 成像核心奖学金计划。其中十个实验室由初级教师指导
助理教授级别的成员。 35 种出版物使用并引用了核心服务。鉴于
在过去的融资周期中核心的广泛使用,以及新成像技术的建立(例如
冷冻电镜和点阵光片)、样品制备服务(例如组织透明化)和分析方法
(例如基于人工智能的免疫组织化学和免疫荧光图像分析),预计要求
细胞和组织成像核心服务将继续增长。刚果民主共和国成员的大量需求
先进的显微成像和图像分析有力地证明了细胞和组织成像核心
提供的服务利用慷慨的机构支持和独特的专业知识来促进重要和
创新的糖尿病研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Alexander Fitzpatrick其他文献
James Alexander Fitzpatrick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Alexander Fitzpatrick', 18)}}的其他基金
Imaging the native 3D architecture of pancreatic and breast tumor patient tissue at single-cell resolution
以单细胞分辨率对胰腺和乳腺肿瘤患者组织的天然 3D 结构进行成像
- 批准号:
10300193 - 财政年份:2021
- 资助金额:
$ 10.37万 - 项目类别:
相似国自然基金
加速器磁铁励磁电源扰动物理机制和观测抑制算法的研究
- 批准号:12305170
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
雀小目鸟类的食性分化与消化酶基因的适应性进化研究
- 批准号:31672272
- 批准年份:2016
- 资助金额:65.0 万元
- 项目类别:面上项目
榕小蜂两性发育关键基因 doublesex 结构及可变剪接的变异与性别分化之间的联系
- 批准号:31601854
- 批准年份:2016
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
基于间质微环境--破骨细胞相互作用优化AOO应用的实验动物学研究
- 批准号:81571002
- 批准年份:2015
- 资助金额:25.0 万元
- 项目类别:面上项目
加速成骨快速正畸(AOO)齿槽骨代谢机制实验动物研究
- 批准号:81171006
- 批准年份:2011
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Silica Nanocapsule-Mediated Nonviral Delivery of CRISPR Base Editor mRNA and Allele Specific sgRNA for Gene Correction in Leber Congenital Amaurosis
二氧化硅纳米胶囊介导的 CRISPR 碱基编辑器 mRNA 和等位基因特异性 sgRNA 非病毒传递用于 Leber 先天性黑蒙的基因校正
- 批准号:
10668166 - 财政年份:2023
- 资助金额:
$ 10.37万 - 项目类别:
Utility of Human Organoids for Safety and Efficiency Evaluations of Genome Editing Therapeutics
人类类器官在基因组编辑治疗安全性和效率评估中的应用
- 批准号:
10667181 - 财政年份:2023
- 资助金额:
$ 10.37万 - 项目类别:
A platform to identify in vivo targets of covalent cancer drugs in 3D tissues
识别 3D 组织中共价癌症药物体内靶标的平台
- 批准号:
10714543 - 财政年份:2023
- 资助金额:
$ 10.37万 - 项目类别:
Deploying Intracortical Electrode Arrays to Record and Stimulate in a Tissue Volume
部署皮质内电极阵列以在组织体积中进行记录和刺激
- 批准号:
10636123 - 财政年份:2023
- 资助金额:
$ 10.37万 - 项目类别:
ENABLING SUBMILLISECOND-TIMESCALE TWO-PHOTON RECORDING OF VOLTAGE DYNAMICS IN THREE DIMENSIONS IN VIVO
实现体内三维电压动态的亚毫秒级双光子记录
- 批准号:
10739579 - 财政年份:2023
- 资助金额:
$ 10.37万 - 项目类别: